Head and Neck Cancers

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect head and neck Cancer Information Center has current, evidence-based information for you. Get the facts about head and neck cancer early detection, treatment, and survivorship, and stay up to date with ongoing head and neck cancer research that could impact your treatment decisions through our daily cancer news.

CancerConnect Head & Neck Cancer Community & Discussions

You are not alone—The CancerConnect Head & Neck Cancer Community is the leading Social Media Application for Head & Neck Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

HEAD AND NECK CANCERS NEWS TIPS & FEATURES

Opdivo Approved for Advanced Head and Neck Cancer

November 28th, 2016

Opdivo Approved for Advanced Head and Neck Cancer

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  […]


Head and Neck Cancer- Your Questions Answered

October 17th, 2016

Head and Neck Cancer- Your Questions Answered

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Present: Ask the Expert with Dr. Kang CancerConnect in […]


Particular HPV Strain Linked to Improved Prognosis for Throat Cancer

October 17th, 2016

Particular HPV Strain Linked to Improved Prognosis for Throat Cancer

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than […]


PET/CT Combined More Effective Than MRI in Monitoring Head and Neck Cancer Patients’ Response to Treatment

October 5th, 2016

PET/CT Combined More Effective Than MRI in Monitoring Head and Neck Cancer Patients’ Response to Treatment

According to a recent study, combining PET/CT to monitor response to treatment in head and neck cancer patients appears more effective than MRI. Using PET/CT […]


Announcing the CancerConnect Head and Neck Cancer Support Community

September 14th, 2016

Announcing the CancerConnect Head and Neck Cancer Support Community

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment […]


Have a Question about Head and Neck Cancer? Ask the Expert!

September 12th, 2016

Have a Question about Head and Neck Cancer? Ask the Expert!

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect […]


Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage

August 29th, 2016

Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage

Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate, […]


Keytruda® Approved for Advanced Head and Neck Cancer

August 24th, 2016

Keytruda® Approved for Advanced Head and Neck Cancer

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding […]


Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer

June 9th, 2016

Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer

Patients with head and neck cancer who comply with their scheduled radiation treatments have significantly improved outcomes compared to those who miss 2 or more […]


Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer

June 8th, 2016

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were […]


More News →